Drug intelligence / Profile preview

fullerenol C60(OH)24

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Fullerenol C60(OH)24 is a water-soluble polyhydroxylated derivative of the C60 fullerene. It acts primarily as a potent antioxidant and free radical scavenger, capable of neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS). In preclinical models of Parkinson's disease, such as those induced by MPTP, fullerenol has demonstrated neuroprotective effects by preserving dopaminergic neurotransmission and modulating the expression of inducible nitric oxide synthase (iNOS) and neuronal nitric oxide synthase (nNOS). Its unique spherical carbon cage structure with multiple hydroxyl groups allows for high solubility and biological activity compared to pristine C60, making it a candidate for treating conditions characterized by high oxidative and nitrosative stress.

Other names
FullerolPolyhydroxylated fullereneC60 fullerolC-60 fullerolC 60 fullerol
02

Targets

DNA

Beyond the preview

Go deeper on fullerenol C60(OH)24.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fullerenol C60(OH)24.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call